Anticancer Action of Xiaoxianxiong Tang in Non-Small Cell Lung Cancer by Pharmacological Analysis and Experimental Validation

Table 2

Information on 20 core targets.

Target name	Betweenness centrality	Closeness centrality	Degree	Overall survival
PTGS2	0.11098661	0.51538462	24
PIK3CG	0.02201518	0.49264706	19
RELA	0.01545686	0.48550725	18
BCL2	0.00792956	0.46527778	12
PRKCB	0.00414970	0.44966443	9
CYCS	0.00182322	0.39181287	7
HIF1A	0.00161744	0.4379085	5
NFATC1	0.00092885	0.36216216	5
IL2	0.00106660	0.42675159	4
BIRC5	0.00043119	0.42675159	3
SERPINE1	0.00046992	0.41358025	3
FOSL1	0.00031530	0.33333333	3
EGLN1	0.00036757	0.36813187	3
CHEK1	0.00063767	0.31018519	2
MMP3	0.00016505	0.40606061	2
SPP1	0.00019974	0.41104294	2
CD40LG	0.00022360	0.41104294	2
HK2	0.00019953	0.41104294	2
FOSL2	0.00009376	0.31162791	2
CCNA2	0.00048920	0.32524272	2